BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas\u2122 Wearable Injector Technology for Biologic Drugs

  • FRANKLIN LAKES, N.J. , July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas\u2122 Wearable Injector for subcutaneous delivery of complex biologics.